Press "Enter" to skip to content

CytoDyn requests FDA meeting to discuss clearance of prostate cancer-detection test – Proactive Investors USA & Canada

admin 0

CytoDyn requests FDA meeting to discuss clearance of prostate cancer-detection test  Proactive Investors USA & Canada

CytoDyn (OTCMKTS:CYDY) – The ProstaGene Prognostic Test is intended for use in patients who have undergone a prostate biopsy and been found to have …

“prostate cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *